CCM
WST icon

Catapult Capital Management’s West Pharmaceutical WST Stock Holding History

Catapult Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,080
Closed -$400K – 256
2014
Q1 		$400K Buy
+9,080
New +$427K 0.08% 168

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Catapult Capital Management's WST Position: Q2 2014 in Review

Catapult Capital Management sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 9,080 shares — an estimated $400K sold.

Catapult Capital Management first reported a position in WST in Q1 2014 and held it in 1 quarter. The position peaked at $400K in Q1 2014. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

  • Catapult Capital Management reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • Catapult Capital Management sold 9,080 West Pharmaceutical shares in Q2 2014, an estimated $400K.
  • Catapult Capital Management first reported a position in West Pharmaceutical in Q1 2014 and held it in 1 quarter.
  • Catapult Capital Management's West Pharmaceutical position peaked at $400K in Q1 2014.
  • 222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on Catapult Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.